As the clock ticks toward January 1, 2024, the Corporate Transparency Act (CTA) is on the verge of reshaping reporting obligations, casting a spotlight on nonexempt entities and triggering implications within the cannabis sector.

The CTA: Background And Objectives

Enacted under the National Defense Authorization Act on January 1, 2021, the CTA was formed to enhance corporate transparency and fortify law enforcement measures against a spectrum of illicit activities, as outlined by the Regulatory Oversight in a recent report.

Entities In Focus And Exemptions

The CTA's jurisdiction spans all domestic U.S. entities and foreign entities registered to operate in the U.S. However, specific exemptions carve out a niche for entities such as securities reporting issuers, governmental authorities and banks.

See Also: State Treasurers Support SAFE Banking For Cannabis, Anti-Money Laundering Specialist Weighs In

Beneficial Owners And Company Applicants

The CTA …

Full story available on Benzinga.com

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.